These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 28857715

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Mestizos with systemic lupus erythematosus develop renal disease early while antimalarials retard its appearance: data from a Latin American cohort.
    Pons-Estel GJ, Alarcón GS, Burgos PI, Hachuel L, Boggio G, Wojdyla D, Nieto R, Alvarellos A, Catoggio LJ, Guibert-Toledano M, Sarano J, Massardo L, Vásquez GM, Iglesias-Gamarra A, Lavras Costallat LT, Da Silva NA, Alfaro JL, Abadi I, Segami MI, Huerta G, Cardiel MH, Pons-Estel BA, Grupo Latino Americano de Estudio de Lupus (GLADEL).
    Lupus; 2013 Aug; 22(9):899-907. PubMed ID: 23857989
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Antimalarial treatment may have a time-dependent effect on lupus survival: data from a multinational Latin American inception cohort.
    Shinjo SK, Bonfá E, Wojdyla D, Borba EF, Ramirez LA, Scherbarth HR, Brenol JC, Chacón-Diaz R, Neira OJ, Berbotto GA, De La Torre IG, Acevedo-Vázquez EM, Massardo L, Barile-Fabris LA, Caeiro F, Silveira LH, Sato EI, Buliubasich S, Alarcón GS, Pons-Estel BA, Grupo Latino Americano de Estudio del Lupus Eritematoso (Gladel).
    Arthritis Rheum; 2010 Mar; 62(3):855-62. PubMed ID: 20131238
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prevalence and predictors of flare after immunosuppressant discontinuation in patients with systemic lupus erythematosus in remission.
    Zen M, Saccon F, Gatto M, Montesso G, Larosa M, Benvenuti F, Iaccarino L, Doria A.
    Rheumatology (Oxford); 2020 Jul 01; 59(7):1591-1598. PubMed ID: 31642908
    [Abstract] [Full Text] [Related]

  • 10. Remission and Low Disease Activity Status (LDAS) protect lupus patients from damage occurrence: data from a multiethnic, multinational Latin American Lupus Cohort (GLADEL).
    Ugarte-Gil MF, Wojdyla D, Pons-Estel GJ, Catoggio LJ, Drenkard C, Sarano J, Berbotto GA, Borba EF, Sato EI, Tavares Brenol JC, Uribe O, Ramirez Gómez LA, Guibert-Toledano M, Massardo L, Cardiel MH, Silveira LH, Chacón-Diaz R, Alarcón GS, Pons-Estel BA, GLADEL.
    Ann Rheum Dis; 2017 Dec 01; 76(12):2071-2074. PubMed ID: 28939626
    [Abstract] [Full Text] [Related]

  • 11. Enteric-coated mycophenolate sodium versus azathioprine in patients with active systemic lupus erythematosus: a randomised clinical trial.
    Ordi-Ros J, Sáez-Comet L, Pérez-Conesa M, Vidal X, Mitjavila F, Castro Salomó A, Cuquet Pedragosa J, Ortiz-Santamaria V, Mauri Plana M, Cortés-Hernández J.
    Ann Rheum Dis; 2017 Sep 01; 76(9):1575-1582. PubMed ID: 28450313
    [Abstract] [Full Text] [Related]

  • 12. Clinical Remission and Low Disease Activity Outcomes Over 10 Years in Systemic Lupus Erythematosus.
    Tselios K, Gladman DD, Touma Z, Su J, Anderson N, Urowitz MB.
    Arthritis Care Res (Hoboken); 2019 Jun 01; 71(6):822-828. PubMed ID: 30055090
    [Abstract] [Full Text] [Related]

  • 13. Features associated with hematologic abnormalities and their impact in patients with systemic lupus erythematosus: Data from a multiethnic Latin American cohort.
    González-Naranjo LA, Betancur OM, Alarcón GS, Ugarte-Gil MF, Jaramillo-Arroyave D, Wojdyla D, Pons-Estel GJ, Rondón-Herrera F, Vásquez-Duque GM, Quintana-López G, Da Silva NA, Tavares Brenol JC, Reyes-Llerena G, Pascual-Ramos V, Amigo MC, Massardo L, Alfaro-Lozano J, Segami MI, Esteva-Spinetti MH, Iglesias-Gamarra A, Pons-Estel BA.
    Semin Arthritis Rheum; 2016 Jun 01; 45(6):675-83. PubMed ID: 26698222
    [Abstract] [Full Text] [Related]

  • 14. The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: results from a monocentric cohort.
    Conti F, Ceccarelli F, Perricone C, Leccese I, Massaro L, Pacucci VA, Truglia S, Miranda F, Spinelli FR, Alessandri C, Valesini G.
    Lupus; 2016 Jun 01; 25(7):719-26. PubMed ID: 26821965
    [Abstract] [Full Text] [Related]

  • 15. Treatment pathways in an inception lupus cohort over the first three years.
    Hanly JG, Sayani A, Doucette S, Iczkovitz S, Terres JAR.
    Lupus; 2017 Feb 01; 26(2):119-124. PubMed ID: 27365369
    [Abstract] [Full Text] [Related]

  • 16. Infections in newly diagnosed Spanish patients with systemic lupus erythematosus: data from the RELES cohort.
    González-Echavarri C, Capdevila O, Espinosa G, Suárez S, Marín-Ballvé A, González-León R, Rodríguez-Carballeira M, Fonseca-Aizpuru E, Pinilla B, Pallarés L, Ruiz-Irastorza G, RELES, Autoimmune Diseases Study Group GEAS.
    Lupus; 2018 Dec 01; 27(14):2253-2261. PubMed ID: 30451641
    [Abstract] [Full Text] [Related]

  • 17. Identification of clinical predictors of flare in systemic lupus erythematosus patients: a 24-month prospective cohort study.
    Inês L, Duarte C, Silva RS, Teixeira AS, Fonseca FP, da Silva JA.
    Rheumatology (Oxford); 2014 Jan 01; 53(1):85-9. PubMed ID: 24067885
    [Abstract] [Full Text] [Related]

  • 18. Age at diagnosis and health-related quality of life are associated with fatigue in systemic lupus erythematosus patients: Data from the Almenara Lupus Cohort.
    Elera-Fitzcarrald C, Reátegui-Sokolova C, Gamboa-Cárdenas RV, Medina M, Zevallos F, Pimentel-Quiroz VR, Zeña-Huancas PA, Pastor-Asurza CA, Perich-Campos RA, Rodríguez-Bellido ZJ, Alarcón GS, Ugarte-Gil MF.
    Lupus; 2020 Oct 01; 29(12):1644-1649. PubMed ID: 32741305
    [Abstract] [Full Text] [Related]

  • 19. Association of systemic lupus erythematosus standard of care immunosuppressants with glucocorticoid use and disease outcomes: a multicentre cohort study.
    de Luca Montes RA, Huq M, Godfrey T, Oon S, Calderone A, Kandane-Rathnayake R, Louthrenoo W, Luo SF, Jan Wu YJ, Golder V, Lateef A, Navarra SV, Zamora L, Hamijoyo L, Sockalingam S, An Y, Li Z, Katsumata Y, Harigai M, Chan M, Goldblatt F, O'Neill S, Lau CS, Cho J, Hoi A, Karyekar CS, Morand EF, Nikpour M.
    Adv Rheumatol; 2024 May 08; 64(1):38. PubMed ID: 38720354
    [Abstract] [Full Text] [Related]

  • 20. High disease activity: an independent factor for reduced immunogenicity of the pandemic influenza a vaccine in patients with juvenile systemic lupus erythematosus.
    Campos LM, Silva CA, Aikawa NE, Jesus AA, Moraes JC, Miraglia J, Ishida MA, Bueno C, Pereira RM, Bonfa E.
    Arthritis Care Res (Hoboken); 2013 Jul 08; 65(7):1121-7. PubMed ID: 23818263
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.